Hemofence Heostatic (Thrombin)
Product Description
BMI Korea
-
KR -
2015On CPHI since
-
3Certificates
-
100 - 249Employees
Company types
Categories
BMI Korea
-
KR
-
2015On CPHI since
-
3Certificates
-
100 - 249Employees
Company types
More Products from BMI Korea (8)
-
Product BM Hylunidase (Lyophilized powder)
Hyaluronidase formulation / 1,500IU -
Product PN skin booster (Lilied)
DNA Healer as medical device / Polydeoxyribonucleotide + Lidocaine / 2ml -
Product Highly purified liquid Hyaluronidase (Rebirax)
Recombinant Hyaluronidase formulation as Liquid type / 1,500IU -
Product Botulinum toxin type A 100 units (Hitox)
Botulinum toxin / Clostridium Botulinum Toxin Type A / 100Unit
Vacuum drying
Storage: 2~8℃
-
Product HA dermal filler (Renefil®)
HA Dermal Filler / Polydeoxyribonucleotide+ HA+Lidocaine / 1ml -
Product Lilied K (Intra-articular injection for knee)
(Polynucleotide 2% + Lidocaine 0.3%) Intra-articular injection for knee -
Product Teriparatide (Under development)
Anti-Osteoporosis / Lyophilized powder / 60.6mg -
Product Recombinant Hyaluronidase (Under development)
Antibodies are regards as anticancer "magic bullet". Monoclonal Antibody (MAb therapeutics) Market will grow USD300 billion in 2025. For these therapeutics, a lot of companies are under development of SC formulation with recombinant Hyaluronidase (using human rHuPH20), and BMI Korea's recombinant hya...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance